Peripheral Neuropathy from Levaquin Caused Permanent and Severe Injury, Lawsuit Alleges

Johnson & Johnson, and it’s Janssen subsidiary, continue face lawsuits over peripheral neuropathy from Levaquin, a popular antibiotic that has been plagued by a number of severe health risks that allegedly were not adequately disclosed by the drug maker.

One of the latest cases was brought by Linda Aslinger, in the U.S. District Court for the District of New Jersey, indicating that the drug maker knew for some time that users may be at risk of suffering severe and permanent nerve damage, yet provided false and misleading information for consumers and the medical community.

In the complaint (PDF) filed last week, Aslinger was prescribed Levaquin to fight an infection, and subsequently developed symptoms like numbness, pain and muscle weakness, which was eventually diagnosed as a form of nerve damage known as peripheral neuropathy.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Levaquin is part of a widely used class of antibiotics, known as fluoroquinolones, which also includes Avelox and Cipro. While the medications have been prescribed for a variety of different infections in recent years, use of the antibiotics has been curtailed over the past year as more information has become available about the risk of peripheral neuropathy and other health problems linked to the drugs.

While Levaquin warnings mentioned that users may experience nerve damage, Aslinger indicates that the drug makers provided false and misleading information.

“The warning label for Levaquin during the period from September 2004 through August 2013 misled Plaintiff and Plaintiff’s treating physician by incorrectly advising patients and physicians that peripheral neuropathy associated with Levaquin was “rare” and in any case could be avoided by discontinuing the drug upon onset of certain symptoms,” alleges Aslinger in the lawsuit. “The truth, however, is that the onset of irreversible peripheral neuropathy is often rapid and discontinuation of the drug will not ensure that the peripheral neuropathy is reversible.”

In August 2013, the FDA required the makers of Levaquin and other fluoroquinolone-based antibiotics, such as Avelox and Cipro, to provide stronger warnings about the peripheral neuropathy risk, adding information to the label for the first time that suggested problems may last for months or years after an individual stops taking the drug. The new label now warns patients to contact their doctors and consider switching to a different class of antibiotics if they experience symptoms of peripheral neuropathy.

The case filed by Aslinger joins more than 400 similar Levaquin lawsuits, Avelox lawsuits and Cipro lawsuits filed throughout the federal court system over peripheral neuropathy caused by the antibiotics.

Given the risk of nerve damage and other injuries associated with the antibiotics, the FDA issued a new drug safety communication in May 2016, urging doctors not to prescribe fluoroquinolones for many common infections that are uncomplicated and have other available treatment options, indicating that the risks associated with the antibiotics outweigh the benefits. The federal regulatory agency considered available information on the risk of peripheral neuropathy, tendon ruptures, retinal detachments and other health concerns linked to the drugs at that time.

More recently, research has also suggested that the same collagen degradation issues that cause the drugs to increase the risk of tendon ruptures and retinal detachment may impact the aorta.

As a result, a growing number of aortic aneurysm lawsuits and aortic dissection lawsuits are also being pursued against the drug makers, alleging that the painful and potentially life-threatening complication may have been avoided if proper warnings had been provided to users of the antibiotics.

2 Comments

  • MargieOctober 12, 2016 at 4:44 am

    I took Levaquin IV. For mycoplasm pneumonia in the early 2000s in 2003 my feet were absolutely killing me to walk. It hurt worse to get back up on my feet after sitting down . Working as a charge nurse in 12 hour shifts I sat very little. I saw a podiatrist who gave it a name of plantar fasciitis. I had ECST to break up the fascia. I never have recovered from the initial pain. Daily activities tha[Show More]I took Levaquin IV. For mycoplasm pneumonia in the early 2000s in 2003 my feet were absolutely killing me to walk. It hurt worse to get back up on my feet after sitting down . Working as a charge nurse in 12 hour shifts I sat very little. I saw a podiatrist who gave it a name of plantar fasciitis. I had ECST to break up the fascia. I never have recovered from the initial pain. Daily activities that require standing are extremely painful and makes shopping is very limited. I now take Neurontin for the peripheral pain . I have since developed diabetes which has only worsened symptoms of neuropathy. A host of others diagnoses also including fibromyalgia, heart disease, hypertension and early renal disease. Last visit to Md was last month and he agreed the beginning of the neuropathy was most likely caused by Levaquin.

  • MarkSeptember 21, 2016 at 6:58 pm

    Hi, Thank you so much for doing articles about fluoroquinolone damage. This is far more common than most people realize. I am the Senior Admin in FLUOROQUINOLONE TOXICITY GROUP, the biggest and busiest of many different facebook groups supporting the FQ community. The vast majority of people who show up in our groups eventually figured it out on their own and has been unable to convince their medi[Show More]Hi, Thank you so much for doing articles about fluoroquinolone damage. This is far more common than most people realize. I am the Senior Admin in FLUOROQUINOLONE TOXICITY GROUP, the biggest and busiest of many different facebook groups supporting the FQ community. The vast majority of people who show up in our groups eventually figured it out on their own and has been unable to convince their medical team of the obvious. Once we read about what others went through and check the dates of our exposure it becomes very obvious. The drug companies and FDA have been sitting on knowledge about horrific damage for a long time. There is even a lawsuit alleging that the former head of FDA Margaret Hamberg withheld information to keep the value of her husbands J$J stock up. Plus Hillary just took Levaquin. We are in the news a lot lately. Google this stuff. You may not qualify for a lawsuit yet, if you are floxed, but you probably will at some point. This is an ongoing crime against humanity. Powerful people belong in prison!

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025
MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025 (Posted 2 days ago)

With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025.